392 related articles for article (PubMed ID: 17997702)
1. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
Boche D; Denham N; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
4. [Abeta vaccine therapy for Alzheimer's disease].
Hara H
Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
[TBL] [Abstract][Full Text] [Related]
5. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
Morgan D; Gitter BD
Neurobiol Aging; 2004; 25(5):605-8. PubMed ID: 15172737
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
Okura Y; Matsumoto Y
Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
9. Current progress in beta-amyloid immunotherapy.
Schenk D; Hagen M; Seubert P
Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
[TBL] [Abstract][Full Text] [Related]
10. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
Okura Y; Matsumoto Y
Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
13. Lessons from the AN 1792 Alzheimer vaccine: lest we forget.
Robinson SR; Bishop GM; Lee HG; Münch G
Neurobiol Aging; 2004; 25(5):609-15. PubMed ID: 15172738
[TBL] [Abstract][Full Text] [Related]
14. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Schenk DB; Seubert P; Grundman M; Black R
Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
[TBL] [Abstract][Full Text] [Related]
15. Anti-Abeta: The good, the bad, and the unforeseen.
Broytman O; Malter JS
J Neurosci Res; 2004 Feb; 75(3):301-6. PubMed ID: 14743443
[TBL] [Abstract][Full Text] [Related]
16. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster JK; Verdile G; Bates KA; Martins RN
Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
Solomon B
Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.
Nicoll JA; Wilkinson D; Holmes C; Steart P; Markham H; Weller RO
Nat Med; 2003 Apr; 9(4):448-52. PubMed ID: 12640446
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
20. Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.
Pride M; Seubert P; Grundman M; Hagen M; Eldridge J; Black RS
Neurodegener Dis; 2008; 5(3-4):194-6. PubMed ID: 18322388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
